21st April 2011

Mirada Medical Workflows for Radiology and Radiation Oncology Collaboration on Show at New CIRT Symposium

Leaders in multidisciplinary cancer imaging software, Mirada Medical will be demonstrating imaging software for collaborative working at the first ever Cancer Imaging and Radiation Therapy Symposium (CIRTS) held at the Atlanta Marriot Marquis, Atlanta, April 29-30 2011. This symposium is is jointly sponsored by the American Society of Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA), both of which hold conferences attended annually by Mirada Medical. “It’s great to see the RSNA and ASTRO coming together in this symposium for multidisciplinary cancer staging and treatment.” says Hugh Bettesworth, CEO of Mirada Medical. “We believe that the multidisciplinary approach needs to extend further and deeper into the tools and technology clinical specialists use for assessing and treating patients. Failure to capitalise on joint working because the tools are not developed with this style of collaboration in mind leads to less efficient and potentially less effective working practice. At Mirada, we have focused our software development on delivering specific imaging workflows for exactly this type of collaboration between radiology and radiation oncology.” Mirada’s XD3 software for oncology can combine images from vendor neutral CT, MR, PET, PET/CT, PET/MRI and SPECT scanners over multiple time points during a patient’s care program, from which important decisions can be made regarding patient progress and the course of treatment. The ability to propagate ROI’s across multiple images and timepoints is further enhanced with semiautomated tools for target definition. The combination of both anatomical and functional images, plus quantification-based ROI tools, gives the user more confidence when defining tumor margins vs. normal tissue for planning purposes. Interconnectivity with treatment planning systems is also an important aspect of the collaborative workflow between radiology and radiation oncology. “The vendor neutral nature of our products means that they can be used with all the major treatment planning companies for transfer of image data and contours” says Bettesworth, “and we are also constantly developing new technologies and workflows for closing the loop between diagnosis, treatment and follow-up assessment. The ability to adjust treatment plans based on new information from imaging at more frequent intervals could have a significant impact on patient outcomes. We are excited to have the opportunity to show our latest developments at CIRTS”. A new product for Mirada Medical, first showcased at the RSNA in November 2010, is Casemeeting, which was developed entirely for clinical specialist collaboration in oncology during tumor board meetings or chart rounds. Casemeeting, also to be demonstrated at the symposium, allows a patient case to be presented and reviewed in a holistic manner, taking inputs from all relevant disciplines and combining them into a simple yet information-rich presentation. In addition to XD3 and Casemeeting, Mirada will also be showcasing new product development utilizing atlas technologies developed by Dr. S. Finkelstein at Moffitt Cancer Center at booth no. 104, April 29-30 during the Cancer Imaging and Radiation Therapy Symposium (CIRTS), Atlanta Marriot Marquis, Atlanta.